BioAge Labs, Inc (BIOA) Stock Chart
BIOA price chart
Daily prices adjusted for splits and dividends. 1D and 5D show delayed intraday prices. Markers: E earnings, D dividend, S split.
Technical snapshot
Key levels & statistics
BIOA performance vs the market
Total return, dividends reinvestedBIOA monthly returns
BIOA historical prices
BIOA dividends & splits
About the BIOA chart
BioAge Labs (BIOA) closed at $4.84 on October 16, 2026, down 63.4% so far this year. The stock is trading 70.4% below its 200-day moving average of $16.33, which technical analysts usually read as a long-term downtrend. Over the past year BIOA returned −5.3% including dividends, behind the S&P 500 (+16.8%).
This page charts the full trading history of BioAge Labs, Inc stock. Daily prices come from EODHD and are adjusted for stock splits and dividends, so returns over long periods are comparable. For the latest quote, company profile, earnings and news, see the BIOA stock overview.
BIOA chart FAQ
What is BioAge Labs's all-time high stock price?
The highest closing price for BIOA was $25.83 on October 21, 2024 (adjusted for stock splits). As of the October 16, 2026 close it traded 81.3% below that level.
What is the 52-week range of BIOA stock?
Over the 52 weeks to October 16, 2026, BIOA traded between an intraday low of $4.81 on October 16, 2026 and an intraday high of $25.95 on July 6, 2026.
Is BIOA above its 200-day moving average?
No. On October 16, 2026 BIOA closed at $4.84, 70.4% below its 200-day simple moving average of $16.33. The 50-day average was $8.43.
How has BIOA stock performed compared with the S&P 500?
Including reinvested dividends, BIOA returned −5.3% over the past year, compared with +16.8% for the S&P 500 (SPY).
Does BioAge Labs pay a dividend?
BioAge Labs has not paid a dividend in the past 12 months.
How do I read the BIOA chart?
Pick a time range above the chart and choose candlesticks, a line or an area chart. Moving averages, Bollinger Bands, volume, RSI and MACD can be switched on with the indicator buttons, and "Compare" plots BIOA against the S&P 500, its sector or a competitor as a percentage change. Chart prices are adjusted for splits and dividends.